APOE and atherosclerosis: In contrast, long-term administration of pharmacological S1P analogs such as fingolimod (FTY720) has reduced atherosclerosis in apolipoprotein E deficient mice (ApoE−/−) and LDLR−/− in some [13,14] but not all studies [15].